retatrutide update october 2025 Today's TRIUMPH-4 results are a clear signal: the next generation of incretin medications will be more powerful than anything we've seen before. is showing nearly 30% body-weight reduction in clinical trials YouTube Music

P., Gupta, K., Kataria, N., Arora, V

Since the COVID-19 pandemic, there is an ongoing debate regarding the question of how firmly scientific findings and recommendations for primary care practice are rooted in high-quality, research-based evidence (294296)

In addition, to gain a deeper understanding of the binding kinetics of antibody modification, we performed time-resolved UV-FAR analyses comparing the conjugation behaviour of haloacetamide and halothioacetamide probes (Fig

Selecting and matching to patients whose characteristics mimic those of people initiating insulin can provide a proxy for a more progressed cohort of patients with T2D

Meanwhile, 74% say they do not plan to take the medications

Nature 1976